“I worked with Dan on a cell and gene therapy business development based project. Dan has a unique, and clearly hard-earned, ability to see through technical and commercial challenges. He was clear and concise in his communication (but at the same time expanding on points when needs be) and easy and enjoyable to work with. ”
About
I believe cell therapies offer potential cures for some of the most devastating…
Activity
-
This morning my Uber driver asked me where I was headed at 4am and I let him know I travel frequently for my #biotech job. He asked if I had heard of…
This morning my Uber driver asked me where I was headed at 4am and I let him know I travel frequently for my #biotech job. He asked if I had heard of…
Liked by Dan Strange
-
Cambridge life science and technology companies have been involved in a dizzying series of acquisitions and fundraisings collectively worth more than…
Cambridge life science and technology companies have been involved in a dizzying series of acquisitions and fundraisings collectively worth more than…
Liked by Dan Strange
-
Conference season is well and truly in full-swing - a lot of stimulating conversations and insights to digest. Started the week with contacts old…
Conference season is well and truly in full-swing - a lot of stimulating conversations and insights to digest. Started the week with contacts old…
Liked by Dan Strange
Experience
Education
Licenses & Certifications
Patents
-
Micro-nozzle assembly with filter
Filed WO2016203225A1
-
Aerosolisation engine for liquid drug delivery
Filed US15310346
Recommendations received
1 person has recommended Dan
Join now to viewMore activity by Dan
-
Last week, I had the privilege of representing Cellular Origins at ROSCon 2024 in Odense, Denmark. As a robotics engineer, it was inspiring to…
Last week, I had the privilege of representing Cellular Origins at ROSCon 2024 in Odense, Denmark. As a robotics engineer, it was inspiring to…
Liked by Dan Strange
-
As cell therapies move from niche treatments to widely approved solutions, there is a growing need to be able to scale up the manufacture of these…
As cell therapies move from niche treatments to widely approved solutions, there is a growing need to be able to scale up the manufacture of these…
Liked by Dan Strange
-
This is so true...Even my children's "books" are on-line, and their work, entertainment and communication with friends will mostly be on-line in the…
This is so true...Even my children's "books" are on-line, and their work, entertainment and communication with friends will mostly be on-line in the…
Liked by Dan Strange
-
Fresh news out of the clinic this week in the #cellandgenetherapy sector. 🧫New allogeneic CAR-T candidate for blood cancers announced from an…
Fresh news out of the clinic this week in the #cellandgenetherapy sector. 🧫New allogeneic CAR-T candidate for blood cancers announced from an…
Liked by Dan Strange
-
Technology Networks caught up with our CTO, Dr. Dan Strange, at Elrig Drug Discovery 2024, where he shared insights on how cutting-edge automation is…
Technology Networks caught up with our CTO, Dr. Dan Strange, at Elrig Drug Discovery 2024, where he shared insights on how cutting-edge automation is…
Liked by Dan Strange
-
This has been a landmark year for cell therapies and the need to scale cell therapies to hundreds of thousands of patients is no longer something…
This has been a landmark year for cell therapies and the need to scale cell therapies to hundreds of thousands of patients is no longer something…
Shared by Dan Strange
-
Inspiring Meeting On The Mesa. Can we structurally reduce the cost of manufacturing cell therapies? Answer is YES. At CellReady™ we are developing…
Inspiring Meeting On The Mesa. Can we structurally reduce the cost of manufacturing cell therapies? Answer is YES. At CellReady™ we are developing…
Liked by Dan Strange
-
My fellow ginger and colleague George White shares his expertise on CAR T cell therpay manufacturing in this BioPharma Reporter interview.
My fellow ginger and colleague George White shares his expertise on CAR T cell therpay manufacturing in this BioPharma Reporter interview.
Liked by Dan Strange
-
As an amateur woodworker, I love this. It’s hard to build something strong and lasting with no glue, no nails, no screws, no nuts & bolts - just…
As an amateur woodworker, I love this. It’s hard to build something strong and lasting with no glue, no nails, no screws, no nuts & bolts - just…
Liked by Dan Strange
-
We’re excited to support The CGT Circle: Cambridge, bringing attention to the important topic of 'Women and Investment' in the CGT industry. Looking…
We’re excited to support The CGT Circle: Cambridge, bringing attention to the important topic of 'Women and Investment' in the CGT industry. Looking…
Liked by Dan Strange
-
Fresenius Kabi and Cellular Origins have announced a partnership to advance the field of cell and gene therapy (CGT) by automating the manufacturing…
Fresenius Kabi and Cellular Origins have announced a partnership to advance the field of cell and gene therapy (CGT) by automating the manufacturing…
Liked by Dan Strange
-
AlphaZero became "the greatest chess playing entity the world's ever seen" following just eight hours of training from scratch. While robot learning…
AlphaZero became "the greatest chess playing entity the world's ever seen" following just eight hours of training from scratch. While robot learning…
Shared by Dan Strange
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Dan Strange in United Kingdom
-
Dan Strange
-
Dan Strange
Entrepreneur, Sports Broadcaster + Voiceover
-
Dan Strange
Technical Consultant at St James’s Place
-
Dan Strange
Illustrator/Digital Artist/Storyboard Artist
26 others named Dan Strange in United Kingdom are on LinkedIn
See others named Dan Strange